By James McCarten, The Canadian Press
WASHINGTON — One of the biggest American manufacturers of protective medical gear went to bat for its Canadian customers Friday as it pushed back against a White House order to stop exporting its surgical-grade face masks — mission-critical armour in the war against COVID-19.
In front of an international backdrop of frenzied buying, dwindling global supply and mounting desperation among North American health-care workers, Minnesota-based 3M appeared poised to defy President Donald Trump’s demand that the company’s American-made masks, known as N95 respirators, be reserved exclusively for the U.S. market.
3M is a “critical supplier” of the masks to Canada and Latin America, the company said in a statement, pointing to the “significant humanitarian implications” of denying protective equipment to health-care workers on the front lines of a fight against a global pandemic. Doing so, it added, might elicit a costly hostile response.
“Ceasing all export of respirators produced in the United States would likely cause other countries to retaliate and do the same, as some have already done,” the statement said.
“If that were to occur, the net number of respirators being made available to the United States would actually decrease. That is the opposite of what we and the administration, on behalf of the American people, both seek.”
Trump, however, appeared unmoved, saying late Friday he would be signing an order under the Defense Production Act to prohibit the export of scarce medical supplies “by unscrupulous actors and profiteers.” It wasn’t immediately clear whether it would apply to 3M.
“We need these items immediately for domestic use,” Trump told a briefing at the White House. “We have to have them.”
Prime Minister Justin Trudeau, by now a veteran of navigating U.S. aggression on the bilateral trade file, tried to strike a diplomatic tone, insisting that Canadian and U.S. emissaries were in ongoing talks to keep goods, services and commerce moving in both directions across a border already closed to non-essential traffic.
In so doing, he relied on a strategy Canada honed during the often-fraught NAFTA talks of 2018: framing U.S. isolationism in terms of the potential consequences for Americans themselves.
“We are receiving essential supplies from the United States, but the United States also receives essential supplies and products and indeed health-care professionals from Canada every single day,” Trudeau said.
“These are things that Americans rely on, and it would be a mistake to create blockages or reduce the amount of back-and-forth trade of essential goods and services, including medical goods, across our border. That is the point we are making very clearly to the American administration right now.”
The frantic scramble for some of medicine’s most basic fixtures — from paper gowns to high-tech ventilators — has provided a terrifying subplot to the mounting COVID-19 caseload and death toll in the U.S., Canada and around the world: more than 1 million cases and nearly 60,000 deaths globally. There are nearly 7,000 deaths in the U.S. alone.
Canada has reported a total of 12,369 confirmed cases, including 178 deaths.
Mark Warner, an international trade lawyer based in Toronto and a veteran of the Canada-U.S. trade dynamic, said he’s concerned that Canada’s efforts to stand on principle in its discussions with the United States risk falling on deaf ears if the crisis continues to worsen.
“We’re in a fight,” Warner said. “There’s a limited quantity of this stuff that’s available, and we’re all fighting for it.”
Demand for so-called personal protective equipment — gloves, gowns, face shields and the all-important N95 masks — has been soaring around the world as overtaxed doctors, nurses and hospitals struggle to manage the spike in COVID-19 cases while protecting themselves.
And now that the Centers for Disease Control and others in the health community have started recommending everyone wear some sort of face covering while out in public, the scarcity of medical-grade masks is sure to get even worse.
A study by the World Trade Organization found that in 2019, China, Germany and the U.S. together produced 40 per cent of all exports of personal protective equipment, which includes masks, hand soap, sanitizer and protective goggles — more than $15 billion worth last year in the case of the United States.
The U.S. also holds about 16 per cent of the export market for ventilators and respirators, second only to Singapore at 18 per cent.
3M, based in St. Paul, Minn., is one of the largest U.S. providers of protective medical gear, second only to North Carolina-based conglomerate Honeywell, which has been expanding and retooling facilities across the continent to ramp up its N95 production.
3M, however, has been singled out for criticism by Trump, who has invoked the U.S.’s Defense Production Act to force companies to prioritize orders from the Federal Emergency Management Agency.
“We hit 3M hard today after seeing what they were doing with their Masks,” Trump tweeted Thursday. “‘P Act’ all the way. Big surprise to many in government as to what they were doing — will have a big price to pay!”
White House trade adviser Peter Navarro said he expected the dispute with 3M to be resolved by “close of business” Friday, “because we can’t afford to lose days or hours, even minutes in this crisis.”
3M says it has already “gone above and beyond” to maximize production of the masks for the U.S. market, and was doing so long before the Defense Production Act was invoked. In an interview Friday with CNBC, president and CEO Mike Roman said any suggestion that the company isn’t going all-out to meet American demand “is just not true.”
Gayle Smith, an expert in international development who once worked as a special assistant to President Barack Obama and as a senior director on the National Security Council, said she believes the U.S. and the world will soon come to the realization that fighting a global pandemic demands a global response.
“It is simply not possible for any country to declare victory and then revert to business as usual,” Smith said in an interview, describing the “congestion” in the medical-supplies market as a temporary condition.
“We’ve got competition within the United States for it, and we’ve got competition of every country with each other for it. That’s just not sustainable, so something’s got to break it loose sometime soon.”
— With files from Mike Blanchfield in Ottawa